Livzon Pharmaceutical
SHE:000513, HKG:01513Zhuhai, China· Est.
A major integrated Chinese pharmaceutical group with strong R&D in microsphere technology, biologics, and traditional Chinese medicine.
Is this your company? Claim your profile to update info and connect with investors.
Claim profileAI Company Overview
A major integrated Chinese pharmaceutical group with strong R&D in microsphere technology, biologics, and traditional Chinese medicine.
GastroenterologyPsychiatry & NeurologyReproductive HealthAutoimmune DiseasesInfectious DiseaseMetabolic DiseaseCardiovascular Disease
Technology Platform
Long-acting microsphere drug delivery platform and integrated biologics/vaccine R&D and manufacturing platforms.
Opportunities
Growth is driven by the launch of novel biologics and complex microsphere formulations, expansion into international markets, and leveraging its integrated traditional Chinese medicine platform for modernization.
Risk Factors
Faces pricing pressure from China's national drug procurement policies, intense domestic competition, and R&D execution risks as it advances a broad pipeline of novel candidates.
Competitive Landscape
Competes with large domestic pharma peers and multinationals in core therapeutic areas; differentiates through its leading microsphere delivery technology and integrated R&D across small molecules, biologics, and中药.